Perioperative Glycaemic Dynamics in Type 2 Diabetes Mellitus: Comparison of Minimally Invasive and Conventional Coronary Artery Bypass

Keywords: сoronary artery disease, сardiac surgery, minimally invasive CABG or CABG, T2DM, CPB або cardiopulmonary bypass, perioperative management, inotropic support, metabolic stress, glucose, integral glycaemic indices

Abstract

Aim. To compare perioperative glycaemic dynamics and the need for inotropic support in patients with type 2 diabetes undergoing minimally invasive versus conventional coronary artery bypass grafting.

Materials and Methods. The study included 60 patients with multivessel coronary artery disease and type 2 diabetes mellitus not treated with insulin. All underwent coronary artery bypass grafting (CABG) with cardiopulmonary bypass. Group 1 (prospective, n=30) underwent minimally invasive CABG (MICS CABG) via left anterior thoracotomy; Group 2 (retrospective, n=30) underwent conventional CABG via sternotomy. Glycaemic levels were assessed perioperatively at six time points, and integral indices (mean AUC, AUC>10) were calculated. Statistical analyses included the Friedman test with post-hoc Wilcoxon comparisons and Spearman correlation for associations with clinical parameters.

Results. Completeness of revascularisation was comparable between groups: the completeness index was 0.95±0.138 in Group 1 and 0.94±0.127 in Group 2 (p=0.811). Operative (Group 1: 341.9±31.6 min; Group 2: 258.4±27.9 min) and perfusion times were longer in the minimally invasive group (p<0.001), reflecting greater technical complexity. However, the sternotomy group showed significantly higher postoperative glucose levels and a greater overall glycaemic load. Mean AUC was 8.3 (7.4-8.9) in Group 1 and 9.7 (8.4-11.1) in Group 2 (p<0.001), along with a longer time in clinically significant hyperglycaemia (AUC>10, p=0.01). These patients also required more frequent (p=0.021) inotropic support with dobutamine, with significantly higher dosing (p=0.018) and longer infusion duration (p=0.037). AUC>10 correlated positively with the mean dobutamine dose (p=0.42, p=0.01).

Conclusions. Minimally invasive CABG, while technically more demanding, provided equivalent revascularisation with reduced metabolic and haemodynamic stress compared with sternotomy. Integral glycaemic indices, particularly AUC>10, emerged as sensitive markers of metabolic stress and potential predictors of inotropic dependence, supporting their role in personalised perioperative management

References

  1. Naito R, Miyauchi K. Coronary artery disease and type 2 diabetes mellitus. Int Heart J. 2017;58(4):475−480. https://doi.org/10.1536/ihj.17-191
  2. Patsouras A, Farmaki P, Garmpi A et al. Screening and risk assessment of coronary artery disease in patients with type 2 diabetes: an updated review. In Vivo. 2019;33(4):1039−1049. https://doi.org/10.21873/invivo.11572
  3. Wong ND, Sattar N. Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention. Nat Rev Cardiol. 2023;20(10):685−695. https://doi.org/10.1038/s41569-023-00877-z
  4. Godoy LC, Tavares CAM, Farkouh ME. Weighing coronary revascularization options in patients with type 2 diabetes mellitus. Can J Diabetes. 2020;44(1):78−85. https://doi.org/10.1016/j.jcjd.2019.08.002
  5. Alsharif, A.; Alsharif, A.; Alshamrani, G.; Abu Alsoud, A.; Abdullah, R.; Aljohani, S.; Alahmadi, H.; Fuadah, S.; Mohammed, A.; Hassan, F.E. Comparing the Effectiveness of Open and Minimally Invasive Approaches in Coronary Artery Bypass Grafting: A Systematic Review. Clin. Pract. 2024, 14, 1842–1868. https://doi.org/10.3390/clinpract14050147
  6. Sljivo A, Hadzimehmedagic A, Serdarevic M et al. Enhanced recovery and reduced complications with minimally invasive coronary artery bypass grafting compared to open sternotomy.ActaInformMed.2025;33(2):135−139. https://doi.org/10.5455/aim.2025.33.135-139
  7. Huang Z, Zhang H, Huang Y et al. Association of time in range with postoperative wound healing in patients with diabetic foot ulcers. Int Wound J. 2021;19(6):1309−1318. https://doi.org/10.1111/iwj.13725
  8. Dobson GP. Trauma of major surgery: a global problem that is not going away. Int J Surg. 2020; 81:47−54. https://doi.org/10.1016/j.ijsu.2020.07.017
  9. Bonatti J, Wallner S, Crailsheim I, Grabenwöger M, Winkler B. Minimally invasive and robotic coronary artery bypass grafting-a 25-year review. J Thorac Dis. 2021;13(3):1922-1944. https://doi.org/10.21037/jtd-20-1535
  10. Gong Y, Ding T, Wang X et al. Minimally invasive vs conventional coronary bypass surgery for multivessel coronary disease. Ann Thorac Surg Short Rep. 2024;3(2):402−407. https://doi.org/10.1016/j.atssr.2024.10.024
  11. Guangxin Z, Liqun C, Lin L et al. The efficacy of minimally invasive coronary artery bypass grafting (MICS CABG) for patients with coronary artery diseases and diabetes: a single center retrospective study. J Cardiothorac Surg. 2024; 19:244. https://doi.org/10.1186/s13019-024-02717-8
  12. Alzghoul H, Weimer J, Antigua A et al. Optimizing postoperative glucose management in CABG patients: exploring early transition to subcutaneous insulin. J Cardiovasc Dev Dis. 2024;11(11):348. https://doi.org/10.3390/jcdd11110348.
  13. Agirbasli M. Influence of diabetes on CABG patency: targeting functional status after CABG in patients with DM. J Am Coll Cardiol. 2017;70(20):2604. https://doi.org/10.1016/j.jacc.2017.07.801
Published
2025-12-25
How to Cite
1.
Dordiai IS, Sobanska LO, Benkovska LK. Perioperative Glycaemic Dynamics in Type 2 Diabetes Mellitus: Comparison of Minimally Invasive and Conventional Coronary Artery Bypass. ujcvs [Internet]. 2025Dec.25 [cited 2025Dec.26];33(4):22-9. Available from: http://cvs.org.ua/index.php/ujcvs/article/view/789